• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Neurochemical responses to 6-hydroxydopamine and L-dopa therapy: implications for Parkinson's disease.

作者信息

Zigmond M J, Hastings T G, Abercrombie E D

机构信息

Department of Behavioral Neuroscience, University of Pittsburgh, Pennsylvania 15260.

出版信息

Ann N Y Acad Sci. 1992 May 11;648:71-86. doi: 10.1111/j.1749-6632.1992.tb24525.x.

DOI:10.1111/j.1749-6632.1992.tb24525.x
PMID:1637074
Abstract
摘要

相似文献

1
Neurochemical responses to 6-hydroxydopamine and L-dopa therapy: implications for Parkinson's disease.对6-羟基多巴胺和左旋多巴治疗的神经化学反应：对帕金森病的影响。
Ann N Y Acad Sci. 1992 May 11;648:71-86. doi: 10.1111/j.1749-6632.1992.tb24525.x.
2
Effect of chronic treatment with angiotensin type 1 receptor antagonists on striatal dopamine levels in normal rats and in a rat model of Parkinson's disease treated with L-DOPA.血管紧张素受体 1 型拮抗剂在正常大鼠和左旋多巴治疗的帕金森病大鼠纹状体多巴胺水平的慢性作用。
Neuropharmacology. 2014 Jan;76 Pt A:156-68. doi: 10.1016/j.neuropharm.2013.07.016. Epub 2013 Aug 20.
3
Potential of neurotrophic factors in therapy of Parkinson's disease.神经营养因子在帕金森病治疗中的潜力。
J Neural Transm Suppl. 1996;48:103-12. doi: 10.1007/978-3-7091-7494-4_10.
4
The unilateral 6-hydroxydopamine lesion model in behavioral brain research. Analysis of functional deficits, recovery and treatments.行为脑研究中的单侧6-羟基多巴胺损伤模型。功能缺陷、恢复及治疗分析。
Prog Neurobiol. 1996 Oct;50(2-3):275-331. doi: 10.1016/s0301-0082(96)00040-8.
5
Characterization of enhanced behavioral responses to L-DOPA following repeated administration in the 6-hydroxydopamine-lesioned rat model of Parkinson's disease.帕金森病6-羟基多巴胺损伤大鼠模型中重复给药后对左旋多巴增强行为反应的特征分析。
Exp Neurol. 1998 Jun;151(2):334-42. doi: 10.1006/exnr.1998.6819.
6
Levodopa induction of Fos immunoreactivity in rat brain following partial and complete lesions of the substantia nigra.左旋多巴对黑质部分和完全损伤大鼠脑内Fos免疫反应性的诱导作用
Exp Neurol. 1993 Apr;120(2):223-32. doi: 10.1006/exnr.1993.1057.
7
Mechanism of action of L-leucyl-glycinamide and its effect on Parkinson's disease.
Adv Neurol. 1987;45:587-90.
8
Neuroprotective effects of L-Dopa-modified zinc oxide nanoparticles on the rat model of 6-OHDA-ınduced Parkinson's disease.L-多巴修饰的氧化锌纳米粒子对 6-OHDA 诱导的帕金森病大鼠模型的神经保护作用。
Sci Rep. 2024 Aug 17;14(1):19077. doi: 10.1038/s41598-024-69324-4.
9
Neuroprotective and neurotoxic roles of levodopa (L-DOPA) in neurodegenerative disorders relating to Parkinson's disease.左旋多巴（L-DOPA）在与帕金森病相关的神经退行性疾病中的神经保护和神经毒性作用。
Amino Acids. 2002;23(1-3):57-63. doi: 10.1007/s00726-001-0110-x.
10
Modulation of the motor response to dopaminergic drugs in a parkinsonian model of combined dopaminergic and noradrenergic degeneration.在多巴胺能和去甲肾上腺素能联合变性的帕金森病模型中对多巴胺能药物运动反应的调节。
Eur J Pharmacol. 2007 Dec 8;576(1-3):83-90. doi: 10.1016/j.ejphar.2007.08.024. Epub 2007 Aug 25.

引用本文的文献

1
Current insights and assumptions on α-synuclein in Lewy body disease.目前对路易体病中α-突触核蛋白的认识和假设。
Acta Neuropathol. 2024 Aug 14;148(1):18. doi: 10.1007/s00401-024-02781-3.
2
Neuroinflammation in Parkinson's Disease - Putative Pathomechanisms and Targets for Disease-Modification.帕金森病中的神经炎症——发病机制假说和疾病修饰靶点。
Front Immunol. 2022 May 18;13:878771. doi: 10.3389/fimmu.2022.878771. eCollection 2022.
3
Tyrosine Hydroxylase, Vesicular Monoamine Transporter and Dopamine Transporter mRNA Expression in Nigrostriatal Tissue of Rats with Pedunculopontine Neurotoxic Lesion.
脚桥核神经毒性损伤大鼠黑质纹状体组织中酪氨酸羟化酶、囊泡单胺转运体和多巴胺转运体mRNA表达
Behav Sci (Basel). 2018 Feb 1;8(2):20. doi: 10.3390/bs8020020.
4
Cross-hemispheric dopamine projections have functional significance.跨半球多巴胺投射具有功能意义。
Proc Natl Acad Sci U S A. 2016 Jun 21;113(25):6985-90. doi: 10.1073/pnas.1603629113. Epub 2016 Jun 13.
5
Lymphocytes reduce nigrostriatal deficits in the 6-hydroxydopamine mouse model of Parkinson's disease.淋巴细胞可减轻帕金森病6-羟基多巴胺小鼠模型中的黑质纹状体缺陷。
J Neural Transm (Vienna). 2015 Dec;122(12):1633-43. doi: 10.1007/s00702-015-1444-y. Epub 2015 Aug 20.
6
Are striatal tyrosine hydroxylase interneurons dopaminergic?纹状体酪氨酸羟化酶中间神经元是多巴胺能的吗？
J Neurosci. 2015 Apr 22;35(16):6584-99. doi: 10.1523/JNEUROSCI.0195-15.2015.
7
Chronic treatment with novel small molecule Hsp90 inhibitors rescues striatal dopamine levels but not α-synuclein-induced neuronal cell loss.新型小分子热休克蛋白90（Hsp90）抑制剂的长期治疗可恢复纹状体多巴胺水平，但不能挽救α-突触核蛋白诱导的神经元细胞损失。
PLoS One. 2014 Jan 20;9(1):e86048. doi: 10.1371/journal.pone.0086048. eCollection 2014.
8
An inverse correlation between the apparent rate of dopamine clearance and tonic autoinhibition in subdomains of the rat striatum: a possible role of transporter-mediated dopamine efflux.大鼠纹状体亚区多巴胺清除率的表观速率与紧张性自动抑制呈负相关：转运体介导的多巴胺外排可能起作用。
J Neurochem. 2011 Apr;117(1):133-42. doi: 10.1111/j.1471-4159.2011.07183.x. Epub 2011 Feb 9.
9
Diffusion in brain extracellular space.脑外间隙中的扩散
Physiol Rev. 2008 Oct;88(4):1277-340. doi: 10.1152/physrev.00027.2007.
10
Proteomic approach to studying Parkinson's disease.蛋白质组学方法在帕金森病研究中的应用
Mol Neurobiol. 2004 Jun;29(3):271-88. doi: 10.1385/MN:29:3:271.